Document is current
Any future updates will be listed below
-
Authors
Qiao, Chexuan
Rolfe, Emanuella De Lucia https://orcid.org/0000-0003-3542-2767
Mak, Ethan https://orcid.org/0009-0009-8904-378X
Sengupta, Akash
Powell, Richard
Watson, Laura P. E.
Heymsfield, Steven B. https://orcid.org/0000-0003-1127-9425
Shepherd, John A.
Wareham, Nicholas https://orcid.org/0000-0003-1422-2993
Brage, Soren https://orcid.org/0000-0002-1265-7355
Cipolla, Roberto
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council
DH | National Institute for Health Research
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 7 October 2024
First Online: 23 October 2024
Competing interests
: S.B.H. declares the following competing interests: Medifast Corporation, Novo Nordisk, Amgen, Abbott, Versanis, Novartis. The remaining authors declare no competing interests.
